Capital Advisory Group Advisory Services, LLC Celularity Inc Transaction History

Capital Advisory Group Advisory Services, LLC

$250 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.43 - $4.31 $2,042 - $20,472	4,750 Added 37.85%	17,300 $40,000
Q2 2022 Aug 12, 2022	BUY	$2.81 - $12.91 $4,355 - $20,010	1,550 Added 14.09%	12,550 $89,000
Q1 2022 Apr 29, 2022	BUY	$3.81 - $9.79 $41,910 - $107,689	11,000 New	11,000 $96,000

Others Institutions Holding CELU

# of Institutions

Shares Held

23.6M

Call Options Held

Put Options Held

Starr International CO Inc Zug, V8

15.3M
Shares

$34.2 Million
16.9% of portfolio
C V Starr & CO Inc New York, NY

7.64M
Shares

$17.1 Million
30.58% of portfolio
Louis Dreyfus Family Office LLC Wilton, CT

720K
Shares

$1.61 Million
2.57% of portfolio

View Full List

About Celularity Inc

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

More about CELU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account